Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hypoxia × Circulating Tumor DNA × Genitourinary × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Prostatic Neoplasms 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Hypoxia 1

Interventions

TH 302 2 Ipilimumab 1 Injections 1 Exercise 1 Circulating Tumor DNA 1 3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 1 3-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05702619 2023-01-27

HYPROGEN

The Christie NHS Foundation Trust

Hypoxia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡